Innhold levert av Jonathan Kaskey. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Jonathan Kaskey eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app Gå frakoblet med Player FM -appen!
In this episode, we welcome back David French, columnist for The New York Times , former constitutional attorney, and author of Divided We Fall . We discuss the current state of American democracy, the challenges of political division, and how we can engage in civil discourse despite deep ideological differences. David also shares a personal update on his family and reflects on the profound trials and growth that come with adversity. 📌 What We Discuss: ✔️ How David and his family navigated the challenges of a serious health crisis. ✔️ The rise of political polarization and the factors driving it. ✔️ Why distinguishing between “unwise, unethical, and unlawful” is crucial in analyzing political actions. ✔️ How consuming different perspectives (even opposing ones) helps in understanding political dynamics. ✔️ The role of Christian values in politics and how they are being redefined. ⏳ Episode Highlights 📍 [00:01:00] – David French’s background and his journey from litigation to journalism. 📍 [00:02:30] – Personal update: David shares his wife Nancy’s battle with cancer and their journey as a family. 📍 [00:06:00] – How to navigate personal trials while maintaining faith and resilience. 📍 [00:10:00] – The danger of political paranoia and the pitfalls of extreme polarization. 📍 [00:18:00] – The "friend-enemy" paradigm in American politics and its influence in Christian fundamentalism. 📍 [00:24:00] – Revisiting Divided We Fall : How America’s divisions have devolved since 2020. 📍 [00:40:00] – The categories and differences of unwise, unethical, and unlawful political actions. 📍 [00:55:00] – The balance between justice, kindness, and humility in political engagement. 📍 [01:00:00] – The After Party initiative: A Christian approach to politics focused on values rather than policy. 💬 Featured Quotes 🔹 "You don't know who you truly are until your values are tested." – David French 🔹 "If we focus on the relational, we can have better conversations even across deep differences." – Corey Nathan 🔹 "Justice, kindness, and humility—if you're missing one, you're doing it wrong." – David French 🔹 "The United States has a history of shifting without repenting. We just move on." – David French 📚 Resources Mentioned David French’s Writing: New York Times David’s Book: Divided We Fall The After Party Initiative – More Info Advisory Opinions Podcast (with Sarah Isgur & David French) – Listen Here 📣 Call to Action If you found this conversation insightful, please: ✅ Subscribe to Talkin' Politics & Religion Without Killin' Each Other on your favorite podcast platform. ✅ Leave a review on Apple Podcasts, Spotify, or wherever you listen: ratethispodcast.com/goodfaithpolitics ✅ Support the show on Patreon: patreon.com/politicsandreligion ✅ Watch the full conversation and subscribe on YouTube: youtube.com/@politicsandreligion 🔗 Connect With Us on Social Media @coreysnathan: Bluesky LinkedIn Instagram Threads Facebook Substack David French: 🔗 Twitter | BlueSky | New York Times Our Sponsors Meza Wealth Management: www.mezawealth.com Prolux Autogroup: www.proluxautogroup.com or www.granadahillsairporttransportation.com Let’s keep talking politics and religion—with gentleness and respect. 🎙️💡…
Innhold levert av Jonathan Kaskey. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Jonathan Kaskey eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
Innhold levert av Jonathan Kaskey. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Jonathan Kaskey eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)
In this episode of Pharma Sessions, hosted by Jonathan Kaskey, Vince Turner shares his insights on integrating creativity into operational environments. The discussion covers Vince's career journey from financial services to pharma, and his operational strategies at Kite. Emphasis is placed on the importance of creativity in solving challenges, the value of building strong relationships, and empowering team members. And stay to the end for the buttermilk pancakes recipe (courtesy of Melissa Clark from NYT)! 00:00 Introduction and Opening Thoughts 00:25 Meet Vince: A Personal Introduction 02:45 Every Day is a New Puzzle: Podcast Theme 03:03 Vince's Career Journey 04:25 Creativity in Operations 12:01 Leadership and Team Building 22:24 Navigating Challenges in Pharma 30:03 Future of Creativity in Pharma 32:42 Conclusion and Pancake Recipe Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of Pharma Sessions, host Jonathan Kaskey talks with Paul Howe, COO at Protega Pharmaceuticals, about the current and evolving landscape of prescription opioids, abuse deterrent technologies, and the role of technology in public health. They discuss new strategies to improve outcomes for chronic pain patients while reducing addiction risks. Introduction and startling data on prescription abuse Welcome and guest introduction Paul Howe's breakfast routine Career background and current role Challenges with opioid prescriptions Risk stratification and mitigation for patients Pharmaceutical manufacturing quotas and regulation Future outlook for pain management and public health Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Bursting the Medical Affairs Bubble: A Conversation on Cross-Functional Collaboration In this episode of Pharma Sessions, host Jonathan Kaskey talks with Dr. Samin Saeed, a pharmaceutical medical affairs leader with 17 years of industry experience currently at GSK. They discuss the need for medical affairs to move beyond speaking only to themselves and to engage more openly with other functions within pharmaceutical organizations. Dr. Saeed advocates for a collaborative approach and shares her insights on fostering better communication and understanding between medical affairs and commercial teams. The conversation also touches on the role of technology and AI, and the ongoing challenge of balancing strategic goals with organizational pressures. 00:00 Introduction and Host Welcome 00:34 Guest Introduction: Dr. Sameen Saeed 00:52 Bursting the Med Affairs Bubble 01:14 The Value of Medical Affairs 02:33 Challenges in Medical Affairs 05:32 Collaboration and Cross-Functional Teams 15:46 The Role of Technology in Pharma 20:13 Ideal Medical Affairs Scenario 25:06 Final Thoughts and Conclusion Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of Pharma Sessions, host Jonathan Kaskey sits down with Steve Cirillo-Thompson, a seasoned Chief of Staff in the pharmaceutical industry, to delve deep into the unique and often misunderstood role of a Chief of Staff. Steve shares his unconventional journey into the medical affairs space, transitioning from political science to consulting, and eventually stepping into various Chief of Staff roles at some of the leading pharmaceutical companies like Shire, Takeda, Abbvie and Kite Pharma. Timestamped Key Points: - 00:02: Introduction to the episode and guest, Steve Cirillo-Thompson. - 00:37: Steve discusses his unconventional background, transitioning from political science to consulting. - 03:12: The move from consulting to industry and the personal career decision behind it. - 06:45: An overview of Steve's roles at Shire, Takeda, and the integration process. - 10:22: Definition and importance of the Chief of Staff role in the pharmaceutical industry. - 12:56: Discussion on the growing prevalence of Chief of Staff roles beyond the C-suite. - 15:43: Benefits of having a Chief of Staff to remove silos and be a change champion. - 18:32: Managing the relationship with the principal and establishing trust. - 21:05: Emotional intelligence and delivering bad news in a high-stress environment. - 23:18: Hard skills versus soft skills in the Chief of Staff role. - 26:53: Insights from the Shire and Takeda integration project. - 30:14: Overcoming imposter syndrome and managing a newly elevated role. - 34:40: The impact of the COVID-19 pandemic on the Chief of Staff role. - 36:18: Applying the Chief of Staff skillset across different industries. - 39:45: The importance of versatility and adaptability in multiple roles. Jonathan and Steve discuss the importance of emotional intelligence, adaptability, and the ability to manage high-stress relationships with top-level executives. They explore the value a Chief of Staff brings in breaking down silos within an organization, acting as a change champion, and enhancing cross-functional communication and coordination. Steve emphasizes the skillset required for the role, balancing hard operational skills with soft skills like empathy and strategic thinking. Steve provides insights into the challenges and rewards of the Chief of Staff role, sharing examples from his career, including navigating company integrations and managing cultural shifts within organizations. He also highlights the growing prevalence of Chief of Staff roles in the pharma industry and their critical importance in today's fast-evolving landscape. Join us for an enlightening conversation filled with practical advice and real-world experiences that can inspire and inform anyone interested in the Chief of Staff role or the pharmaceutical industry at large. Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Jen Mohawk, Senior Director of Medical Affairs at Apogee Therapeutics. They discuss the pressing issue of burnout, its financial implications, and how companies benefit from retaining employees rather than constantly seeking new hires. Jen shares her journey from academia to the biopharma industry, driven by her pursuit of a sustainable work-life balance. They delve into practical strategies for integrating work and personal life, the importance of setting boundaries, and the benefits of work-life integration. Jen also explains her mid-Monday movement initiative and its impact on productivity and well-being. T he conversation highlights the evolving perception of work-life balance and the positive changes seen in various industries. 00:00 The Cost of Burnout 00:15 Introduction to Pharma Sessions 00:43 Meet Jen Mohawk 01:44 Jen's Career Journey 02:45 The Importance of Work-Life Balance 03:27 Challenges in Academia 04:20 Transition to MSL Role 05:36 Working from Home 06:45 Setting Boundaries and Priorities 11:06 Work-Life Integration 18:36 Mid Monday Movement 21:26 Resources and Recommendations 24:25 Reevaluating Work-Life Balance 26:16 Future of Work-Life Balance 27:33 Conclusion Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Future Proofing Medical Affairs: A Conversation with Stephanie Hunter Banks In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Stephanie Hunter-Banks about the future of the medical science liaison (MSL) role and the evolving healthcare ecosystem. Stephanie shares insights on creating a culture of innovation, leveraging big data and AI, and fostering collaboration within pharma companies. She reflects on her own career journey from pharmacy to leading learning and development teams, emphasizing the importance of failure, curiosity, and experimentation in driving medical advancements. They also discuss the integration of diverse data sets to enhance patient outcomes and the potential of AI tools in transforming MSL operations. Stephanie envisions medical affairs taking on a leadership role in the industry, improving patient care through strategic data analysis and enhanced stakeholder engagement. 00:00 Introduction to Pharma Sessions 01:11 Stephanie Hunter Banks' Career Journey 02:24 The Role of Medical Science Liaisons (MSLs) 06:27 Innovations in Medical Affairs 13:07 Leveraging Data and AI in Pharma 30:06 Future of Medical Affairs Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Kaskey's Hierarchy of Needs in Medical Affairs: Steering towards Successful Product Launches This episode of Pharma Sessions delves into the evolving role of Medical Affairs in pharmaceutical launches, emphasizing its transition from a supportive to a strategic partnership position. Stephen Dodge, SVP of Medical Affairs at Madrigal Pharmaceuticals has launched 25 products, and shares insights into the crucial involvement of Medical Affairs in launch strategies. The discussion translates the framework of Maslow's Hierarchy of Needs to Medical Affairs, particularly during product launches. Key areas discussed include understanding the foundational needs of Medical Affairs, such as organizational structure and the essential skills for personnel, as well as higher-level needs like engagement with key opinion leaders, evidence generation, and publication planning. The episode also touches on the importance of transitioning from planning to execution, ensuring effective communication and ongoing refinements to meet the ultimate goal of a successful product launch. 00:00 Welcome to Pharma Sessions: The Evolution of Medical Affairs 00:33 The Impact of AI on Medical Affairs: Insights from MAPS Annual Meeting 00:58 Exploring the Hierarchy of Needs in Medical Affairs 02:16 A Deep Dive into the Medical Affairs Professional's Journey 04:57 The Strategic Role of Medical Affairs in Pharmaceutical Launches 08:24 Building the Foundation: Organizational Structure and Team Dynamics 13:32 Elevating Medical Affairs: From Strategy to Execution 27:27 The Pinnacle of Medical Affairs: Achieving Self-Actualization in Launch Success 33:02 Reflecting on the Fulfillment and Complexity of Medical Product Launches The views expressed on this episode are our own and do not reflect those of our respective employers. Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of Pharma Sessions, host Jonathan Kaskey speaks with Lars Dreesmann, the President and Site Head for Boehringer Ingelheim Fremont about how regulatory affairs can impact patient care. They explore the challenges and opportunities in the regulatory space, including the impact of technology and AI on regulatory affairs and the potential for collaboration between pharmaceutical companies. Lars shares his transition from academia to the pharmaceutical industry, the thrill of turning science into tangible products benefiting patients, and the strategic importance of regulatory processes. The conversation delves into how artificial intelligence could revolutionize data management and reporting in pharma manufacturing, and the complexities of producing biosimilars compared to original biologics. The podcast highlights the industry's collaborative spirit, shared goals to enhance drug manufacturing processes, and excitement for future scientific breakthroughs that could lead to curing currently incurable diseases. 00:00 Introduction to Smart Risk Taking 00:24 Welcome to Pharma Sessions 00:43 Guest Introduction: Lars Driessmann 01:20 Lars' Journey from Academia to Pharma Industry 03:01 The Role of Regulatory Processes in Pharma Manufacturing 17:08 The Impact of Technology on Regulatory Affairs 24:12 The Challenges and Opportunities in Biosimilars 34:26 The Future of Pharma Industry: A Look Ahead Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
This episode is sponsored by Acceleration Point. Pharma Sessions is hosted by Jonathan Kaskey In this episode Jonathan and Scott Thompson, the Co-CEO of Acceleration Point, discuss the impact of Artificial Intelligence (AI) on Medical Affairs. Examples of AI use in Medical Affairs include analytics, content creation, and productivity enhancements. Scott encourages experimentation with secure, customized AI tools to improve output. He outlines a case study where AI improved data quality and speed of information processing. Scott and Jonathan ultimately envision a world where AI technologies will help Medical Affairs expand its reach, improve communication, and increase its impact in the medical community. 00:18 Understanding the Role of AI in Med Affairs 00:46 Guest Introduction: Scott Thompson, Co-CEO of Acceleration Point 03:12 The Evolution of AI in Medical Affairs 04:46 The Impact of AI on Big Data and Medical Affairs 06:03 The Three Buckets of AI Application in Med Affairs 09:53 Overcoming Fear and Resistance to AI 13:12 The Future of AI in Medical Affairs 20:18 Case Study: Successful AI Implementation in a Global Med Affairs Team 30:18 Conclusion and Farewell Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Life is different at a biotech. But is that a good thing? Like so much in life, the answer is, "it depends." On this episode I speak with Orlando Granado-Balaez about his journey from being a nurse to transitioning into medical affairs and ultimately thriving in smaller pharmaceutical companies. He shares his experiences in different roles within medical affairs, including being the first MSL in a company and the challenges and rewards that come with building out a team. Orlando also provides advice for individuals considering a transition from larger companies to start-up environments in medical affairs, emphasizing understanding the role, asking right questions, and maintaining a learning mindset. 00:00 Introduction to the Podcast 00:25 The Journey from Big Pharma to Biotech 01:21 Personal Career Path and Transition into Medical Affairs 02:49 The Appeal of Startups and the Concept of Pivoting 03:30 Experience in Small Pharma and the Transition from Big Companies 05:09 Building a Medical Affairs Team from Scratch 06:02 The Challenges and Rewards of Leadership in a Startup 07:57 The Hiring Process and Building a Team 09:59 The Importance of Fit and Transparency in Hiring 11:07 The Role of Consultation and Networking in Career Transition 26:04 The Future of Medical Affairs and Final Thoughts Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
The Science of Sleep: Exploring its Role in Performance and Well-being for Medical Affairs In this episode of Pharma Sessions, Jonathan Kaskey is joined by Dr. Alison Kole, a sleep expert, to discuss the importance of sleep and its impact on personal and professional health. They discuss the dangers of insufficient and poor-quality sleep, including poor cognitive and creative function. On the other hand, they stress the benefits of prioritizing good quality sleep for enhanced productivity, improved mood and better physical health. The episode also covers practical advice on achieving good sleep, including creating regular bedtime and wake time habits, being mindful of light exposure before bedtime, yielding to drowsiness when it occurs, and managing jet lag. The podcast concludes with the implications of new sleep research technology and the potential downside of relying too heavily on consumer wearables for sleep information. 00:00 Introduction to the Importance of Sleep 00:19 Welcome to Pharma Sessions Podcast 01:00 Exploring the World of Sleep with Dr. Allison Kole 01:46 Dr. Allison Kole's Journey into Sleep Research 04:23 The Impact of Sleep Deprivation 04:39 The Role of Sleep in Medical Affairs 06:28 The Importance of Adequate Sleep 07:47 The Dangers of Sleep Deprivation 08:24 The Effects of Sleep Deprivation on Work Performance 16:46 The Impact of Alcohol on Sleep 21:44 Tips for Better Sleep Management 23:10 The Importance of Regular Wake Time 23:27 Creating a Pre-Bedtime Routine 23:48 Understanding Your Sleep Pattern 24:23 Creating a Relaxing Environment Before Bed 24:52 Personal Bedtime Routine and Reflection 26:26 The Role of Reading in Sleep 27:49 Sleep Tips for Travelers 28:08 Understanding Jet Lag 33:39 Creating a Work-Life Balance for Better Sleep 40:44 The Future of Sleep Research and Technology Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this compelling episode of Pharma Sessions, host Jonathan Kaskey engages in an insightful discussion with esteemed guest Jose Borbolla-Escoboza. Delving into the intricacies of global launch excellence, Jose, a seasoned oncologist, shares his wealth of experience in pharmaceuticals, particularly in Mexico, the UK, and the US. Together, they explore the multifaceted process of global launch preparation and the crucial role of global in facilitating tools for local country launches. Jose's expertise shines through as he emphasizes proactive communication and the pivotal role of Medical Affairs in navigating regulatory timelines and managing access programs. The episode offers a comprehensive understanding of the challenges, strategies, and skill sets involved in launching medical products in diverse global markets. It's an illuminating conversation that delves into the complexities of achieving global drug access while recognizing the need for strategic adaptation at the local level. Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of "Pharma Sessions," host Jonathan Kaskey delves into the crucial topic of why negotiation skills are essential in the field of medical affairs. Joining him, Megan Vignos, Head of Scientific and Value Communications for US Medical at Biogen. Together, they explore the importance of negotiation in medical affairs, and how a scientific mindset can aid in building effectiveness. Megan emphasizes the significance of maintaining a positive relationship with compliance officers, avoiding an adversarial approach, and employing the experimental method to foster curiosity and better comprehend compliance decisions. Drawing from her own experience as a medical science liaison and subsequent roles as an associate medical director and medical director, Megan shares personal anecdotes that highlight the increasing need for negotiation skills at each level of one's career. She offers valuable insights on negotiating with partners, understanding and aligning priorities, and exploring alternative bargaining options beyond financial aspects. Throughout their discussion, Jonathan and Megan tackle the topic of negotiation in various contexts, from negotiating with habitually late attendees during meetings to negotiating job offers and career progression. They address common fears and misconceptions about negotiation, emphasizing that being a strong negotiator can demonstrate value and effectiveness, both in job offers and when collaborating with cross-functional partners. Tune in to this enlightening episode of "Pharma Sessions," where Jonathan and Megan unveil the vital role negotiation skills play in medical affairs, offering practical strategies and insights to help navigate the world of negotiation in the healthcare industry. Don't miss the chance to enhance your negotiation expertise and achieve better outcomes in your professional endeavors. Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
In this episode of Pharma Sessions, host Jonathan Kaskey interviews Dr. Huma Qamar, Head of Clinical Development and Medical Affairs at Ocugen, Inc. With her extensive background in clinical research and medicine, Dr. Qamar has been a pioneer in merging these two fields. Throughout this episode, she shares her invaluable insights on gene therapy, specifically focusing on inherited retinal diseases. Here are the top five things you'll learn: 1. The importance of patient-centered outcomes research and the different phases of clinical trials. 2. The challenges and advancements in developing gene therapies for unmet medical needs. 3. How to navigate the regulatory landscape of gene therapy and the role of the FDA in this process. 4. The significance of patient-reported outcomes and how they impact clinical development and medical affairs. 5. The future of gene therapy, including its potential to revolutionize healthcare and improve patients' quality of life. Subscribe to the PharmaSessions substack for exclusive content and show updates: www.pharmasessions.substack.com Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Join host Jonathan Kaskey in this thought-provoking episode of Pharma Sessions as he invites special guest Denise Bronner, Director of Clinical Trial Diversity and Inclusion at Janssen, to delve into critical issues facing the pharmaceutical industry. Together, they explore the challenges of data sharing, the underrepresentation of non-white individuals in clinical trials, and the need for more inclusive physician training. Top 5 learnings from the episode: The critical need for data sharing in the pharmaceutical industry and how it can foster innovation. The concerning lack of representation of non-white individuals in clinical trials and the reasons behind this disconnect. The importance of analyzing claims data and site-specific data to uncover the underlying issues affecting patient enrollment in clinical trials. The crucial role of healthcare access, implicit bias, and community engagement in empowering underrepresented populations. The steps being taken by pharmaceutical companies and society to drive diversity, equity, and inclusion in healthcare. Tune in to this eye-opening episode of Pharma Sessions and be part of the movement to advance health equity, bridge the gaps in clinical trials and physician training, and ensure that all patients receive the care they deserve. Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com Pharma Sessions is hosted by Jonathan Kaskey Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/ Or join the Pharma Sessions Substack: www.pharmasessions.substack.com…
Velkommen til Player FM!
Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.
Bli med på verdens beste podcastapp for å håndtere dine favorittserier online og spill dem av offline på vår Android og iOS-apper. Det er gratis og enkelt!